Komori
Koa Shoji Holdings (9273) · RiskDropped

Downside Risk to the Global Economy from the Spread of the Novel Coronavirus

First written in FY2020-Q3. 5 of 13 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2024.

13entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020-Q3 – FY2021-Q1WorsenedFY2021-Q2 – FY2021-Q3WorsenedFY2022-Q2 – FY2022-Q3RestatedFY2023-Q2WorsenedFY2024-Q12020: 220202021: 420212022: 320222023: 320232024: 12024
Same theme, other companies
Economic slowdown and decline in customer demand due to COVID-19A theme 191 companies write about · 191 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 110 of 173 companies on the "Worse" side.

55 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 191 companies compared. The sentences above are computed from all 191.
Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report
    The current fiscal year's discussion of the economic environment does not identify the spread of COVID-19 as a major current economic risk and describes the normalization of economic activity. The risk-response section still refers to measures taken against past outbreaks, but that description has been removed as a statement of current risk.
  2. FY2024-Q1WorsenedAnnual report

    「COVID-19 was reclassified as a Class 5 disease under the legal framework, economic activity resumed and the economy showed signs of recovery. However, the number of COVID-19 infections in Japan increased sharply」

    While describing the reclassification of COVID-19 as a Class 5 disease and the resumption of economic activity, the company newly highlighted the sharp increase in infections in Japan, indicating that infection risks had strengthened again in some respects.
  3. FY2023MitigatedAnnual report

    「In this environment, the impact of COVID-19 on the Group's results was minor.」

    The company stated that the impact on the Group's results was minor as COVID-19 was reclassified under the legal framework as a Class 5 disease and economic activity resumed in full.
  4. FY2023-Q2RestatedAnnual report

    「In this environment, the impact of COVID-19 on the Group's results was minor.」

    While the renewed spread of COVID-19 and uncertainty in the economic environment continued, the company reaffirmed its recognition that the impact on the Group's results was minor.
  5. FY2023-Q1MitigatedAnnual report

    「During the first three months of the fiscal year, economic activity in Japan began moving toward normalization amid the renewed spread of COVID-19. However, the outlook remained uncertain due to the rapid depreciation of the yen, soaring fuel and raw-material prices, and the prolonged Russia-Ukraine situation. In this environment, the impact of COVID-19 on the Group's results was minor.」

    Although infections were spreading again, economic activity was moving toward normalization, and the company stated that the impact on the Group's results was minor.
  6. FY2022-Q3WorsenedAnnual report

    「During the first nine months of the fiscal year, the Japanese economy showed signs of recovery from the spread of COVID-19 due to the effects of vaccinations and other measures, but, in addition to the renewed spread of new variants in Japan and overseas,」

    Although there had been signs of recovery, the company stated that new variants had spread again in Japan and overseas, and that uncertainty about the outlook due to infectious diseases had increased from the previous quarter.
  7. FY2022-Q2WorsenedAnnual report

    「During the first six months of the fiscal year, the Japanese economy showed signs of recovery from the spread of COVID-19 due to the effects of vaccinations and other measures. However, infections caused by the new Omicron variant, first identified in November 2021, were beginning to trend upward, and uncertainty about the outlook continued.」

    While there were signs of recovery due to vaccinations and other measures, the company pointed to the increasing spread of infections caused by the new Omicron variant and continued uncertainty about the outlook, indicating that the infection-risk situation had worsened from the previous quarter.
  8. FY2022-Q1MitigatedAnnual report

    「During the first three months of the fiscal year, although there were concerns about the spread of COVID-19 in Japan, the number of infections declined due to the effects of vaccinations and other measures, and the state of emergency measures and priority preventive measures were lifted in all prefectures. Economic activity is therefore expected to recover gradually.」

    As the number of infections declined due to vaccinations and other measures and the restrictions were lifted in all prefectures, concerns about downside risks to the economy from the spread of infections have eased from the previous quarter.
  9. FY2021MitigatedAnnual report

    「Based on the above, the company recognizes that, at present, the impact of the spread of COVID-19 on the business activities of the Group is minor. Although there are risks such as disruptions to imports and sharp fluctuations in raw-material purchase prices caused by exchange-rate movements, the company also recognizes that the impact on results is minor given current inventory levels.」

    Although the spread of infections and downside risks to the economy remain, the company recognizes that the impact on business activities and results was minor as of the end of the fiscal year.
  10. FY2021-Q3WorsenedAnnual report

    「During the first nine months of the fiscal year, the Japanese economy remained uncertain, as COVID-19 infections began increasing again and a state of emergency was declared again.」

    The company stated that uncertainty about the outlook continued as COVID-19 infections began increasing again and a state of emergency was declared again.
  11. FY2021-Q2WorsenedAnnual report

    「During the first six months of the fiscal year, the Japanese economy showed signs of recovery from the spread of COVID-19, but infections were again beginning to trend upward, and uncertainty about the outlook continued.」

    It was noted that infections began trending upward again after signs of recovery and that uncertainty about the outlook would continue. The impact on results during the first six months of the fiscal year was described as minor.
  12. FY2021-Q1RestatedAnnual report

    「During the three-month cumulative first quarter period, the Japanese economy showed gradual signs of recovery from the April-June period, when real GDP recorded its worst postwar contraction due to the impact of COVID-19. However, overseas outbreaks continued unabated, raising concerns that the recovery of the global economy would be delayed.」

    While the domestic economy is showing signs of recovery, concerns remain over the continued spread of infections overseas and a delayed recovery in the global economy.
  13. FY2020-Q3First statedAnnual report

    「The risk of a global economic downturn is increasing due to the spread of COVID-19, and the Company expects the difficult-to-predict situation to continue.」

    The Company newly explicitly identified the global economic downturn risk caused by the spread of COVID-19 during the quarter. Although the spread itself was occurring, the Company recognized that its current impact on the group's business activities was limited.
Moved together

"Sustained Growth and Stronger Profitability" moved the same way as this thread, in the same document, in 4 of its 13 moves.

42222★12345
  1. ★This thread
  2. 1Sustained Growth and Stronger Profitability4×
  3. 2Continued Investment in Sales Capabilities, Production Capacity, and R&D Capabilities2×
  4. 3Expansion of production facilities at the Zao Plant and annual capacity of 2.5 million units2×
  5. 4Market expansion driven by the 80% target for generic drug use2×
  6. 5Transition to a Company with an Audit and Supervisory Committee and Use of Outside Directors2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Koa Shoji Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Downside Risk to the Global Economy from the Spread of the Novel Coronavirus | KOA SHOJI HOLDINGS CO.,LTD. (9273) | Komori